Literature DB >> 8622713

Effect of melatonin on mitotic and proliferation indices, and sister chromatid exchange in human blood lymphocytes.

R J Reiter, B Z Leal, M L Meltz.   

Abstract

Cells from human peripheral blood were cultured in vitro in the presence of 0.05 to 1.00 mM melatonin, 10(-7) M mitomycin C (positive control) and 0.5% ethanol (solvent control) for 72 h at 37 +/- 1 degree C. Lymphocytes were examined for mitotic and proliferation indices, and for the incidence of sister chromatid exchange. The results indicate that the lymphocytes which were cultured in the presence of > or = 0.20 mM concentrations of melatonin exhibited a significant and concentration-dependent decrease in mitotic index and alteration in proliferation kinetics. This was demonstrated by an increase in the frequency of lymphocytes in their first division, with a concomitant decrease in the second and third or later division cells. The incidence of sister chromatid exchange was similar in the lymphocytes exposed to 0.05 to 1.00 mM melatonin and untreated controls. Exposure of the cells to ethanol, the solvent used, did not alter either the mitotic or proliferation indices, or the frequency of sister chromatid exchange. The lymphocytes treated with mitomycin C showed the expected decrease in mitotic and proliferation indices, and an increased incidence of sister chromatid exchange. These observations indicate that melatonin, when continuously present in the cultures for 72 h at the concentrations tested, while not genotoxic as indicated by the sister chromatid exchange assay, inhibits the proliferation of mitogen stimulated (and proliferating) human blood lymphocytes at supraphysiological concentrations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622713     DOI: 10.1016/0027-5107(95)00238-3

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  8 in total

1.  Cytogenetic and oxidative alterations after exposure of cultured human whole blood cells to lithium metaborate dehydrate.

Authors:  Fatih Çağlar Çelikezen; Başak Toğar; Fatma Betül Özgeriş; Mehmet Sait İzgi; Hasan Türkez
Journal:  Cytotechnology       Date:  2015-02-14       Impact factor: 2.058

2.  Multiple binding sites for melatonin on Kv1.3.

Authors:  Z Varga; G Panyi; M Péter; C Pieri; G Csécsei; S Damjanovich; R Gáspár
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

3.  Melatonin and its day and night rhythm of alterations in familial mediterranean Fever: a brief research letter.

Authors:  Ugur Musabak; Guldem Kilciler; Ahmet Uygun; Murat Kantarcıoglu; Zulfukar Polat; Rahsan I Sagkan; Sait Bagci
Journal:  Open Rheumatol J       Date:  2011-02-04

4.  Radioprotective potential of melatonin against ⁶⁰Co γ-ray-induced testicular injury in male C57BL/6 mice.

Authors:  Shahanshah Khan; Jawahar Singh Adhikari; Moshahid Alam Rizvi; Nabo Kumar Chaudhury
Journal:  J Biomed Sci       Date:  2015-07-24       Impact factor: 8.410

Review 5.  Oral Mucositis: Melatonin Gel an Effective New Treatment.

Authors:  Ahmed Esmat Abdel Moneim; Ana Guerra-Librero; Javier Florido; Ying-Qiang Shen; Beatriz Fernández-Gil; Darío Acuña-Castroviejo; Germaine Escames
Journal:  Int J Mol Sci       Date:  2017-05-07       Impact factor: 5.923

Review 6.  Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.

Authors:  Russel J Reiter; Sergio A Rosales-Corral; Dun-Xian Tan; Dario Acuna-Castroviejo; Lilan Qin; Shun-Fa Yang; Kexin Xu
Journal:  Int J Mol Sci       Date:  2017-04-17       Impact factor: 5.923

7.  A case-referent study: light at night and breast cancer risk in Georgia.

Authors:  Sarah E Bauer; Sara E Wagner; Jim Burch; Rana Bayakly; John E Vena
Journal:  Int J Health Geogr       Date:  2013-04-17       Impact factor: 3.918

Review 8.  Common sense: folk wisdom that ethnobiological and ethnomedical research cannot afford to ignore.

Authors:  Thomas C Erren; Melissa S Koch; V Benno Meyer-Rochow
Journal:  J Ethnobiol Ethnomed       Date:  2013-12-02       Impact factor: 2.733

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.